Trial Profile
A Prospective, Multicenter, Single Arm, Post-Market, Real-World Global Registry Assessing the Clinical Use and Safety of the LUTONIX Drug Coated Balloon Catheter in Arteries of the Lower Extremity (LUTONIX Lower Extremity Global (LEG) Registry)
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 14 Jul 2016
Price :
$35
*
At a glance
- Drugs Paclitaxel (Primary)
- Indications Peripheral arterial disorders
- Focus Adverse reactions; Therapeutic Use
- Sponsors CR Bard
- 12 Jul 2016 Status changed from active, no longer recruiting to discontinued due to less patients enrolment.
- 24 May 2016 Planned End Date changed from 1 Jun 2017 to 1 Jun 2016.
- 24 May 2016 Planned primary completion date changed from 1 Jun 2017 to 1 Jun 2016.